Medical Cannabis for Multiple Sclerosis - Spasticity and Pain

Spasticity in multiple sclerosis is one of the best-documented indications for medical cannabis. In many countries a ready-made cannabis medicine (nabiximols, known as Sativex) is registered specifically to treat MS spasticity when other drugs fail.

That's an important starting point: this isn't about empty promises, but a symptom where cannabis has real, studied action. Below: what exactly it eases, what it won't do, and how to add it to therapy without giving up neurological treatment.

Medical cannabis in multiple sclerosis acts mainly on three troublesome symptoms:

Some patients also see better bladder control and overall daily comfort, because less pain and better sleep carry over into everything else.

Spasticity is tension that won't let go - the muscle stays stiff, sometimes cramping painfully at night. Standard drugs (baclofen, tizanidine) don't work for everyone or weaken muscles too much.

This is where cannabis comes in. Preparations with a balanced THC and CBD ratio can relax that tension and reduce cramps, often without such strong loss of muscle strength. The effect is individual - clear in some, moderate in others.

Medical cannabis eases MS symptoms. It doesn't cure the disease or stop its progression - that's the role of disease-modifying therapy (DMT), managed by a neurologist.

So we treat cannabis as symptomatic support alongside neurological therapy, not instead of it. Don't stop drugs prescribed by your neurologist on your own - any change is agreed with the doctor managing your MS.

The first qualifying visit costs 169 PLN and takes 20-30 minutes. Bring your records from the neurology clinic - the MS diagnosis and a list of current medications speed up and organize qualification.

Book a visit in person in Krakow, Bydgoszcz and Toruń, or call +48 731 000 645. On the pain mechanism itself, see our article on cannabis for chronic pain.